Table 6.
Comparison of the co-morbidities present in the two groups
| Co-morbid | Number in cisplatin group (%) | Number in noncisplatin group (%) |
|---|---|---|
| N = 200 | N = 200 | |
| Diabetes Mellitus | 30 (15) | 24 (12) |
| Hypertension | 46 (23) | 52 (26) |
| Coronary artery disease | 10 (5) | 08 (4) |
| Prior Atrial fibrillation | 04 (2) | 04 (2) |
| Prior history of TIA/Stroke | 02 (1) | 00 |
| Renal Failure | 00 | 00 |
| Heart Failure | 00 | 00 |